Joseph P. Lucia & Associates, LLC Amarin Corp Plcuk Transaction History

Joseph P. Lucia & Associates, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	BUY	$2.85 - $3.73 $1,638 - $2,144	575 New	575 $2,000
Q4 2021 Feb 04, 2022	SELL	$3.24 - $5.18 $1,863 - $2,978	-575 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$4.04 - $5.31 $2,323 - $3,053	575 New	575 $3,000
Q3 2020 Oct 20, 2020	SELL	$3.64 - $7.76 $14,086 - $30,031	-3,870 Closed	0 $0
Q2 2020 Jul 10, 2020	BUY	$4.78 - $8.26 $3,465 - $5,988	725 Added 23.05%	3,870 $27,000

Q1 2020 Apr 22, 2020	SELL	$4.0 - $21.53 $3,740 - $20,130	-935 Reduced 22.92%	3,145 $13,000
Q4 2019 Jan 23, 2020	BUY	$13.94 - $24.12 $11,570 - $20,019	830 Added 25.54%	4,080 $87,000
Q3 2019 Oct 15, 2019	SELL	$13.89 - $23.16 $2,014 - $3,358	-145 Reduced 4.27%	3,250 $49,000
Q2 2019 Jul 23, 2019	SELL	$16.27 - $20.51 $1.02 Million - $1.29 Million	-62,703 Reduced 94.86%	3,395 $66,000
Q1 2019 May 02, 2019	BUY	$12.61 - $22.33 $833,495 - $1.48 Million	66,098 New	66,098 $3.4 Million

3.55M

36.9K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $6.59B
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.